We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Countering earlier concerns, a real-world study shows that a widely used at-home COVID-19 test called BinaxNOW is as effective at detecting omicron as other coronavirus variants.
eMed™ announced a partnership with the State of Ohio to distribute and administer at least 2 million virtually-guided, BinaxNOW™ at-home COVID-19 rapid tests, which deliver results within minutes.
Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of COVID-19 infection.